Civic Intelligence

Dlg4 Research Fund

EIN 88-4118178 • 501(c)3 • Allen, TX

990-N CoverageNTEE H12

Profile

Our mission is to improve the lives of individuals with DLG4 Synaptopathy by supporting research developing treatments and therapies and providing a community of support. We understand the challenges that families face when dealing with this rare disease and we are committed to making a difference. By collaborating with researchers healthcare professionals and other organizations we aim to accelerate medical advances focused on the treatment and cure of DLG4 Synaptopathy.

1031 Kenilworth StreetAllen, TX 75013

www.dlg4researchfund.org

Siviq Scores

Scores are not available for this record yet.

Balance Sheet

Assets

Up

$100,600

Up $7,070 (+7.6%) from 2023

Liabilities

-

No earlier filing loaded for comparison.

Net Assets

Up

$100,600

Up $7,070 (+7.6%) from 2023

Operations

Revenue

Down

$56,893

Down $112,370 (-66%) from 2023

Expenses

Down

$49,823

Down $59,068 (-54%) from 2023

Net Income

Down

$7,070

Down $53,302 (-88%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$150K$100K$50K$0Assets 2023: $93,530Net Assets 2023: $93,5302023Assets 2024: $100,600Net Assets 2024: $100,6002024

Highlighted filing

2024

Assets$100,600
Liabilities-
Net Assets$100,600

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$200K$150K$100K$50K$0Revenue 2023: $169,263Expenses 2023: $108,891Net Income 2023: $60,3722023Revenue 2024: $56,893Expenses 2024: $49,823Net Income 2024: $7,0702024

Highlighted filing

2024

Revenue$56,893
Expenses$49,823
Net Income$7,070

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Apr 24, 2025
Return Version
2024v5.0
Gross Receipts
$56,893
Mission and Program Overview

Mission

Our mission is to improve the lives of individuals with DLG4 Synaptopathy by supporting research developing treatments and therapies and providing a community of support. We understand the challenges that families face when dealing with this rare disease and we are committed to making a difference. By collaborating with researchers healthcare professionals and other organizations we aim to accelerate medical advances focused on the treatment and cure of DLG4 Synaptopathy.

Our mission is to improve the lives of individuals with DLG4 Synaptopathy by supporting research, developing treatments and therapies, and providing a community of support. We understand the challenges that families face when dealing with this rare disease, and we are committed to making a difference. By collaborating with researchers, healthcare professionals, and other organizations, we aim to accelerate medical advances focused on the treatment and cure of DLG4 Synaptopathy.

Program Services

DescriptionGrantsExpenses
Harvard Stem Cell Core$34,698$34,698
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Payal PatelPresidentPT$0--
Sonam ArnejaVice President-$0--
Kruti DajeeSecretary-$0--
Sabrina MerchantScience DirectorPT$0--
Jay PatelTreasurer-$0--
Filing and Contact Details

Filer

Filer Name
Dlg4 Research Fund
EIN
88-4118178
Address
1031 Kenilworth Street, Allen, TX 75013

Signing Officer

Name
Payal Patel
Title
President
Signed
2025-04-24
Supplemental Narrative

Additional Explanations

Part I, Line 10

Harvard Stem Cell Core 1033 Masschusetts Ave Cambridge, MA 02138 We had to create more Induces Pluripoten Stem Cells (iPSC's) on different variants to study the disease further. We also expanded iPSC's from 1 vial to 16 vials which will be used to send to various researchers. Which is why we spent the money creating research assets to understand the mechanism of the disease

Part I, Line 16

Other Program expenses- (Program Costs-Other)

Raw XML Appendix136 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0Jay Patel
IRS990EZ/BooksInCareOfDetail/PhoneNum02143356657
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt01031 Kenilworth Street
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Allen
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0TX
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd075013
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt090284
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0100600
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/CntrctRcvdGreaterThan100KCnt00
IRS990EZ/ContributionsGiftsGrantsEtcAmt056893
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt07070
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt0965
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt093530
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0100600
IRS990EZ/GrantsAndSimilarAmountsPaidAmt034698
IRS990EZ/GrossReceiptsAmt056893
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt093530
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0100600
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt093530
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0100600
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt030.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt325.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt42.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Payal Patel
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Sonam Arneja
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Kruti Dajee
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Sabrina Merchant
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4Jay Patel
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Vice President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Secretary
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Science Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Treasurer
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/BOYAmt03246
IRS990EZ/OtherAssetsTotalDetail/EOYAmt00
IRS990EZ/OtherEmployeePaidOver100kCnt00
IRS990EZ/OtherExpensesTotalAmt014160
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0Our mission is to improve the lives of individuals with DLG4 Synaptopathy by supporting research, developing treatments and therapies, and providing a community of support. We understand the challenges that families face when dealing with this rare disease, and we are committed to making a difference. By collaborating with researchers, healthcare professionals, and other organizations, we aim to accelerate medical advances focused on the treatment and cure of DLG4 Synaptopathy.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Harvard Stem Cell Core
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt034698
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt034698
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt049823
IRS990EZ/TotalProgramServiceExpensesAmt034698
IRS990EZ/TotalRevenueAmt056893
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt033158
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0169263
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt037363
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0239784
IRS990ScheduleA/OtherSupportSumAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.59890
IRS990ScheduleA/PublicSupportPY170Pct00.00000
IRS990ScheduleA/PublicSupportTotal170Amt0143613
IRS990ScheduleA/SubstantialContributorsTotAmt096171
IRS990ScheduleA/SupportedOrganizationsCnt00
IRS990ScheduleA/SupportedOrganizationsTotalCnt00
IRS990ScheduleA/SupportSumAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt033158
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0169263
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt037363
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0239784
IRS990ScheduleA/TotalSupportAmt0239784
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Harvard Stem Cell Core 1033 Masschusetts Ave Cambridge, MA 02138 We had to create more Induces Pluripoten Stem Cells (iPSC's) on different variants to study the disease further. We also expanded iPSC's from 1 vial to 16 vials which will be used to send to various researchers. Which is why we spent the money creating research assets to understand the mechanism of the disease
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Other Program expenses- (Program Costs-Other)
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Part I, Line 10
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Part I, Line 16
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/PersonNm0Payal Patel
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-04-24
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0DLG4 RESEARCH FUND
ReturnHeader/Filer/BusinessNameControlTxt0DLG4
ReturnHeader/Filer/EIN0884118178
ReturnHeader/Filer/USAddress/AddressLine1Txt01031 Kenilworth Street
ReturnHeader/Filer/USAddress/CityNm0Allen
ReturnHeader/Filer/USAddress/StateAbbreviationCd0TX
ReturnHeader/Filer/USAddress/ZIPCd075013
ReturnHeader/ReturnTs02025-04-24T19:47:52Z
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.